UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002865
Receipt number R000003493
Scientific Title Risk factors of catheter-related blood stream infection in non-tunneled central venous catheter
Date of disclosure of the study information 2009/12/11
Last modified on 2015/04/06 12:35:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk factors of catheter-related blood stream infection in non-tunneled central venous catheter

Acronym

IVH study

Scientific Title

Risk factors of catheter-related blood stream infection in non-tunneled central venous catheter

Scientific Title:Acronym

IVH study

Region

Japan


Condition

Condition

Any conditions requiring central venous catheter in general hospitals (adult patients)

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Cardiology Pneumology Endocrinology and Metabolism
Hematology and clinical oncology Nephrology Neurology
Clinical immunology Infectious disease Surgery in general
Gastrointestinal surgery Hepato-biliary-pancreatic surgery Chest surgery
Obstetrics and Gynecology Urology Anesthesiology
Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Catheter-related blood stream infection (CRBSI) following insertion of central venous catheter (CVC) can be fatal complication which results in huge medical expense. According to the Guidelines for the prevention of intravascular catheter-related infections issued by Centers for Disease Control and Prevention, use of maximal sterile barrier precautions (MSBPs) during CVC insertion, using a cap, mask, sterile gown, sterile gloves, and a large sterile sheet, was recommended as category IA. However, our multi-center randomized controlled trial demonstrated that there was no difference of CRBSI rates between MSBPs and standard sterile barrier precautions (SSBPs) groups. The guideline also recommended use of 2% chlorhexidine solution for skin hygiene on CVC insertion but use of the dose is prohibited in Japan. Therefore, we should not blindly obey the CDC guideline in Japan and should create our own prevention strategy in our clinical settings.
This study was undertaken to elucidate risk factors of CRBSI following CVC insertion and to establish its prevention strategy in Japan.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

catheter-related blood steam infection

Key secondary outcomes

cases in which catheter is removed due to suspicious catheter-related blood steam infection


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Any patients over 19 years old who required non-tunneled central venous catheter.

Key exclusion criteria

1) patients who are under 18 years old
2) patients who have high fever over 38.1 cent degree
3) patients who were already administered antibiotics
4) patients who already had central venous catheter
5) patients who do not sign a consent form

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaharu Odo

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Department of Surgery

Zip code


Address

1-5 Ninomaru, Kumamoto 8600008, Japan

TEL

096-353-6501

Email

epass2006@ybb.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Haga

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Institute for Clinical Research

Zip code


Address

1-5 Ninomaru, Kumamoto 8600008, Japan

TEL

096-353-6501

Homepage URL


Email

yoshio@kumamed.jp


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Background: Risk factors for catheter-related bloodstream infections (CRBSIs) may change over time with progress in infection control. This study was undertaken to explore the current risk factors for CRBSIs in hospitalized patients.

Methods: Adult patients with non-tunneled central venous catheters (CVCs) in 12 Japanese referral hospitals were prospectively enrolled between December 2009 and January 2012. Patients were monitored for CRBSIs for up to 8 weeks from CVC insertion; data were collected regarding patient characteristics, the purpose of CVC insertion, insertion methods, mechanical complications during insertion, and post-insertion catheter care.

Results: A total of 892 patients were enrolled in this study. The overall incidence of CRBSIs was 0.40 infections per 1000 catheter-days. Univariate analysis using the Fisher's exact test identified one of the participating hospitals (hospital A; p < 0.001), internal jugular vein catheterization (IJVC) (p = 0.0013), not using maximal sterile barrier precautions (p = 0.030), and the Seldinger technique for catheter insertion (p = 0.025) as significant risk factors for CRBSI. After excluding data from hospital A, only IJVC remained a significant risk factor for CRBSI (p = 0.025). The cumulative probability of remaining without CRBSI was significantly lower in patients with IJVCs than in patients with other catheter routes (p < 0.001; log-rank test). Similarly, the cumulative probability of remaining without catheter removal due to a suspected infection was significantly lower in patients with IJVCs (p = 0.034; log-rank test).

Conclusions: The current study suggests that IJVC might be a risk factor for CRBSI under current infection control conditions.

This article was published online in Scand J Infect Dis.

Read More: http://informahealthcare.com/doi/abs/10.3109/00365548.2013.807936

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2010 Year 01 Month 01 Day

Last follow-up date

2012 Year 02 Month 01 Day

Date of closure to data entry

2012 Year 03 Month 01 Day

Date trial data considered complete

2012 Year 09 Month 13 Day

Date analysis concluded



Other

Other related information

1. Study design: multi-center prospective cohort study
2. Data collection
A. Variables to be investigated
1) Baseline data: age, gender, primary disease, co-morbidity, type of ward, department
2) Purpose of CVC insertion
3) Site of CVC insertion
4) Skin hygiene method on CVC insertion
5) Type of sterile barrier precaution: MSBPs or SSBPs
6) How to puncture vein: direct puncture or Seldinger method; ultrasound-guided or not
7) Number of punctures on insertion
8) Number of lumen of catheter
9) Complications on insertion
10) Dressing methods
11) Duration of dressing change
12) Skin hygiene method on dressing change
13) Presence or absence of antibiotics administration during observation
14) Type of line connector system: open or closed
15) Presence or absence of in-line filter
16) Duration of catheterization
17) Reason for catheter removal
18) Type of microorganisms detected by blood cultures
B. Observational period: All patients were observed until the catheter was removed or until 8 weeks after catheterization.
3. Statistical analysis
1) Significant variables demonstrating significant differences of the incidences of primary endpoint will be identified using chi-square tests.
2) Using these significant variables, independent factors which associate with primary endpoint will be identified via a logistic regression analysis.
3) Based on these results, we will establish prevention strategy for catheter-related blood stream infection.


Management information

Registered date

2009 Year 12 Month 09 Day

Last modified on

2015 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003493


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name